INSIGHTS ON DRUG DEVELOPMENT

• Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity

  Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.

• How Adept Formulation Helps Overcome Manufacturability Challenges

  Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

• Data-Driven Strategies To De-Risk OSD Development

  Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.

• Development Of Separation Methods for GLP-1 Synthetic Peptides

  Peptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.

• 5 Key Considerations For Companies Outsourcing Process Development

  6/9/2025

  Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.

• 3 Key Considerations In Gene Therapy Manufacturing

  7/15/2025

  Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

• Simplify And Streamline Method Development With In Silico Modeling

  5/19/2026

  Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

• Comprehensive Workflow For The Quantification Of Peptides And Proteins

  7/29/2025

  Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.

• Are You Keeping Pace With Oligo Synthesis Optimization?

  11/18/2025

  The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.